The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Superficial Bladder Cancer: Progression and Recurrence
Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., Hawkins, I. R., & For National Bladder Cancer Collaborative Group A S002253471751695X-1bb6d6502e02ba4ea1210f9f5bd6022d George R. Prout The principal investigators and institutions that contributed to the study are, M. G. H. (1983) · Journal of Urology · doi:10.1016/s0022-5347(17)51695-x · Cited by 924
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Böhle, A., & Palou-Redorta, J. (2008) · European Urology · doi:10.1016/j.eururo.2008.04.051 · Cited by 723
Raitanen, M.-P., Aine, R., Rintala, E., Kallio, J., Rajala, P., Juusela, H., & Tammela, T. L. J. (2002) · European Urology · doi:10.1016/s0302-2838(02)00006-4 · Cited by 217
HALLING, K. C., KING, W., SOKOLOVA, I. A., KARNES, R. J., MEYER, R. G., POWELL, E. L., SEBO, T. J., CHEVILLE, J. C., CLAYTON, A. C., KRAJNIK, K. L., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65072-0 · Cited by 188
Urinary Markers in Bladder Cancer
Vrooman, O. P. J., & Witjes, J. A. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.006 · Cited by 176
Accuracy of Urine Cytology and the Significance of an Atypical Category
Brimo, F., Vollmer, R. T., Case, B., Aprikian, A., Kassouf, W., & Auger, M. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpprzlg9kt9axl · Cited by 159
Self-citationComplement factor H or a related protein is a marker for transitional cell cancer of the bladder.
Kinders, R. J., Jones, T., Root, R., Bruce, C. L., Murchison, H. A., Corey, M. J., Williams, L., Enfield, D. L., & Hass, G. M. (1998) · PubMed · Cited by 127
Urine markers for detection and surveillance of bladder cancer
Xylinas, E. N., Kluth, L. A., Rieken, M., Karakiewicz, P. I., Lotan, Y., & Shariat, S. F. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.06.001 · Cited by 114
Yafi, F. A., Brimo, F., Auger, M., Aprikian, A. G., Tanguay, S., & Kassouf, W. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.09.011 · Cited by 111
Self-citation
Cited by
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Powles, T., Bellmunt, J., Comperat, E., De Santis, M., Huddart, R., Loriot, Y., Necchi, A., Valderrama, B. P., Ravaud, A., Shariat, S. F., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2021.11.012 · Cited by 555
Developing proteomic biomarkers for bladder cancer: towards clinical application
Frantzi, M., Latosinska, A., Flühe, L., Hupe, M. C., Critselis, E., Kramer, M. W., Merseburger, A. S., Mischak, H., & Vlahou, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.100 · Cited by 83
Metadata
- Authors
- Yafi, F. A., Brimo, F., Steinberg, J., Aprikian, A. G., Tanguay, S., & Kassouf, W.
- Venue
- Urologic Oncology: Seminars and Original Investigations
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 33
- Issue
- 2
- Pages
- 66.e25-66.e31
- ISSN
- 1078-1439 (ISSN-L)
- OpenAlex
- W2135532181
- Cited by
- 346
- References
- 12
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. https://app.cochat.ai/papers/10.1016/j.urolonc.2014.06.008
- The paper
- Yafi, F. A., Brimo, F., Steinberg, J., Aprikian, A. G., Tanguay, S., & Kassouf, W. (2015). Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2014.06.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
